Stocks and Investing
Stocks and Investing
Mon, November 11, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, November 8, 2019
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Amsellem Maintained (TEVA) at Hold with Increased Target to $7 on, Nov 8th, 2019
David Amsellem of Piper Sandler, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Hold with Increased Target from $6 to $7 on, Nov 8th, 2019.
David has made no other calls on TEVA in the last 4 months.
There are 5 other peers that have a rating on TEVA. Out of the 5 peers that are also analyzing TEVA, 3 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jacob Hughes of "Wells Fargo" Maintained at Hold with Decreased Target to $8 on, Monday, September 30th, 2019
- Rohit Vanjani of "Guggenheim" Initiated at Hold on, Thursday, September 12th, 2019
- Vamil Divan of "Credit Suisse" Initiated at Hold on, Wednesday, July 10th, 2019
These are the ratings of the 2 analyists that currently disagree with David
- Chris Schott of "JP Morgan" Maintained at Sell with Decreased Target to $7 on, Friday, September 6th, 2019
- David Risinger of "Morgan Stanley" Downgraded from Hold to Sell and Decreased Target to $6 on, Monday, July 15th, 2019